Effects of cytokinins, cytokinin ribosides and their analogs on the viability of normal and neoplastic human cells

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3401-3406

  Casati, Silvana ^a   Ottria, Roberta ^a   Baldoli, Erika ^a   Lopez, Elisa ^a   Maier, Jeanette A M ^a   Ciuffreda, Pierangela ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Antiproliferative activity; Cytokinins; Isopentenyladenosine; Modified nucleosides

Indexed keywords

6 N (3,3 DIMETHYLALLYL)ADENOSINE; 6 N BENZYLADENINE; 6 N BENZYLADENOSINE; ADENOSINE DERIVATIVE; CISPLATIN; CYTOKININ; CYTOKININ RIBOSIDE; N 6 ALLYLADENOSINE; N 6 BUTYLADENOSINE; N 6 ISOPENTENYLADENINE; N 6 ISOPENTYLADENOSINE; O 6 BENZYLHYPOXANTHINE; O 6 BENZYLINOSINE; O 6 ISOPENTENYLHYPOXANTHINE; O 6 ISOPENTENYLINOSINE; UNCLASSIFIED DRUG; ZEATIN; ZEATIN DERIVATIVE; ZEATIN RIBOSIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; CANCER CELL; CANCER INHIBITION; CANCER RESISTANCE; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; OSTEOSARCOMA; OVARY CARCINOMA; PRIORITY JOURNAL; TOXICITY TESTING; UMBILICAL VEIN ENDOTHELIAL CELL;

ADENOSINE; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; CYTOKININS; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; ISOPENTENYLADENOSINE; NEOPLASMS; NEUTRAL RED; RIBONUCLEOSIDES; TUMOR STEM CELL ASSAY; ZEATIN;

EID: 80054717684     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Chen CM: Cytokinin biosynthesis and interconversion. Physiol Plant 101(4): 665-673, 1997.
2. Miller CO, Skoog F, Von Saltza MH and Strong M: Kinetin, a cell division factor from deoxyribonucleic acid. J Am Chem Soc 77(5): 1392, 1955.
3. Mok MC: Cytokinins and plant development an overview. In: Cytokinins: Chemistry, Activity and Function. Mok DWS and Mok MC (eds.). Boca Raton, FL: CRC Press, pp. 155-166, 1994.
4. Shaw G: Chemistry of adenine cytokinins. In: Cytokinins: Chemistry, Activity and Function. Mok DWS and Mok MC (eds.) Boca Raton, FL: CRC Press, pp. 15-34, 1994.
5. Tanimoto S and Harada H: Effect of cytokinin and anticytokinin on the initial stage of adventitious bud differentiation in the epidermis of Torenia stem segments. Plant Cell Physiol 23(8): 1371-1376, 1982.
6. Fajkus J, Fulneckova J, Hulanova M, Berkova K, Riha K and Matyasek R: Plant cells express telomerase activity upon transfer to callus culture, without extensively changing telomere lengths. Mol Gen Genet 260(5): 470-474, 1998. (Pubitemid 29015287)
7. Faust JR and Dice JF: Evidence for isopentenyladenine modification on a cell cycle-regulated protein. J Biol Chem 266(15): 9961-9970, 1991. (Pubitemid 21906749)
8. 6-(2-isopentenyl) adenosine, and 2-O-methylguanosine as determined by radio-immunoassay for normal subjects and cancer patients. Cancer Res 42(12): 5265-5269, 1982.
9. Barciszewski J, Mielcarek M, Stobiecki M, Siboska G and Clark BFC: Identification of 6-furfuryladenine (kinetin) in human urine. Biochem Biophys Res Commun 279(1): 69-73, 2000.
10. Ottria R, Casati S, Maier JAM, Mariotti M and Ciuffreda P: Novel isopentenyladenosine analogues: Synthesis, characterization and evaluation of antiproliferative activity on bladder carcinoma cells. Nucleos Nucleot Nucl 28(8): 736-751, 2009.
11. Ottria R, Casati S, Manzocchi A, Baldoli E, Mariotti M, Maier JAM and Ciuffreda P: Synthesis and evaluation of in vitro anticancer activity of some novel isopentenyladenosine derivatives. Bioorg Med Chem 18(12): 4249-4254, 2010.
12. 6-Alkyladenosines: synthesis and evaluation of in vitro anticancer activity. Bioorg Med Chem 18(25): 8396-8402, 2010.
13. Repetto G, del Peso V and Zurita JL: Neutral red uptake assay for the estimation of cell/cytotoxicity. Nat Protoc 3(7): 1125-1131, 2008.
14. 6 to C-8 in the guanine series. Double labeling experiments. J Am Chem Soc 96(18): 5894-5903, 1974.
15. Villar JDF and Motta MA: Synthesis of 6-alkyl- and arylamino-9- (tetrahydro-2-pyranyl)purines via 6-methylsulfonylpurine. Nucleosides Nucleotides 19(5-6): 1005-1016, 2000.
16. Brajeswar P, Chen FM and Paterson RPA: Inhibitors of nucleoside transport. Structure activity study using human erythrocytes. J Med Chem 18(10): 968-973, 1975.
17. Huang L-K, Cherng Y-C, Cheng Y-R, Jang J-P, Chao Y-L and Cherng Y-J: An efficient synthesis of substituted cytosines and purines under focused microwave irradiation. Tetrahedron 63(24): 5323-5327, 2007. (Pubitemid 46702213)
18. Slaugenhaupt SA, Mull J, Leyne M, Cuajungco MP, Gill SP, Hirns MM, Quintero F, Axelrod FB and Gusella JF: Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. Hum Mol Genet 13(4): 429-436, 2004. (Pubitemid 38239794)
19. Berge U, Kristensen P and Rattan SI: Kinetin-induced differentiation of normal human keratinocytes undergoing aging in vitro. Ann NY Acad Sci 1067(1): 332-336, 2006. (Pubitemid 43810010)
20. Wu JJ, Weinstein GD, Kricorian GJ, Kormeili T and McCullough JL: Topical kinetin 0.1% lotion for improving the signs and symptoms of rosacea. Clin Exp Dermatol 32(6): 693-695, 2007. (Pubitemid 47609755)
21. Mittelman A, Evans JT and Chheda GB: Cytokinins as chemotherapeutic agents. Ann NY Acad Sci 255: 225-234, 1975.
22. Tiedemann RE, Mao X, Shi CX, Zhu YX, Palmer SE, Sebag M, Marler R, Chesi M, Fonseca R, Bergsagel PL, Schimmer AD and Stewart AK: Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity. J Clin Invest 118(5): 1750-1764, 2008. (Pubitemid 351632378)
23. 6-alkyladenosines. J Med Chem 11(4): 717-720, 1968.
24. 6-Substituted adenosines. Synthesis, biological activity, and some structure - activity relations. J Med Chem 15(2): 187-191, 1972.
25. Perego P, Gatti L, Righetti SC, Beretta GL, Carenini N, Corna E, Dal Bo L, Tinelli S, Colangelo D, Leone R, Apostoli P, Lombardi L, Beggiolin G, Piazzoni L and Zunino F: Int J Cancer 105(5): 617-624, 2003.
26. Errani C, Longhi A, Rossi G, Rimondi E, Biazzo A, Toscano A, Ali N, Ruggieri P, Alberghini M, Picci P, Bacci G and Mercuri M: Palliative therapy for osteosarcoma. Expert Rev Anticancer Ther 11(2): 217-227, 2011.